Company intelligence / Profile preview

BR Pharma

Leeds, West Yorkshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

BR Pharmaceuticals is a UK-based pharmaceutical company that specializes in the development, supply, and distribution of over-the-counter (OTC) healthcare products and generic medicines. The company is best known for its flagship brand, Valupak, which offers an extensive range of vitamins, minerals, and nutritional supplements. Operating globally, BR Pharmaceuticals exports its products to numerous international markets, focusing on providing high-quality and affordable healthcare solutions. The company maintains a strong presence in the retail pharmacy sector and continues to expand its product portfolio to meet diverse consumer health needs.

Therapeutic areas: NeurologyOtherGastroenterologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on BR Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BR Pharma.

Explore the full profile